Stock Market & Financial News
Wall Street Analysts See Hyster-Yale (HY) as a Buy: Should You Invest?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
HY -0.46% Dutch Bros (BROS) Is Considered a Good Investment by Brokers: Is That True?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
BROS -4.35% Why Lam Research (LRCX) is a Top Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
LRCX -0.55% Is It Worth Investing in DraftKings (DKNG) Based on Wall Street's Bullish Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
DKNG -1.46% 
Earnings Growth & Price Strength Make Starbucks (SBUX) a Stock to Watch
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
SBUX -2.64% 
Why Advanced Micro Devices (AMD) is a Top Stock for the Long-Term
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
AMD -2.03% 
Virtu Financial (VIRT) Boasts Earnings & Price Momentum: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
VIRT -0.52% 
Brokers Suggest Investing in Marathon Digital (MARA): Read This Before Placing a Bet
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
MARA -2.62% 
Wall Street Bulls Look Optimistic About XPeng (XPEV): Should You Buy?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
XPEV +3.66% 
Brokers Suggest Investing in Axon (AXON): Read This Before Placing a Bet
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
AXON +1.34% 
Wall Street Analysts Think CleanSpark (CLSK) Is a Good Investment: Is It?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
CLSK -1.27% 
Wall Street Bulls Look Optimistic About Lilly (LLY): Should You Buy?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
LLY +0.83% 
Adma Biologics (ADMA) Is Considered a Good Investment by Brokers: Is That True?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
ADMA +0.29% 
Alphabet Stock Is Pulling Back From Its High. Here's Why I'd Buy the Dip.
Alphabet just posted blowout earnings and yet the stock has shed more than 10% from its peak, leaving investors caught between soaring Cloud growth and a balance sheet that suddenly looks very different from a year ago.
GOOG +0.87% 
Tuesday's First Moves: BE Joining SPX, AMGN & NVS Fall, PANW Downgrade
Amgen (AMGN) shares sold off after Novartis (NVS) failed to meet its primary endpoint in phase-3 trials. Diane King Hall offers more insight into the volatile moves in the healthcare space.
SPXC +0.52% 
Fortescue: Look No Further If You Want Iron Ore Exposure
Fortescue delivered robust FY2026 cash flows, with 246Mt ore mined and a 9% revenue increase to nearly US$97B. FSUMF generated US$3.8B in free cash flow and declared a full-year A$1.08 dividend, yielding 6.1% with a 65% payout ratio. The balance sheet remains strong, with US$5.07B cash and net debt just over US$230M despite heavy dividend payouts.
FSUGY -1.78% 
BDJ: A Solid Income Fund That I Wouldn't Buy Yet
BlackRock Enhanced Equity Dividend Trust (BDJ) is rated Hold due to a less compelling risk/reward profile at its current 7% discount to NAV. BDJ's portfolio has shifted from diversified value to concentrated mega-cap tech, with Microsoft now at 12.5% of assets, altering its risk dynamics. The covered-call strategy, while historically respectable, has recently produced realized losses in a strong bull market and structurally caps upside.
BDJ +1.27% 
Here's Why You Should Retain ABM Stock in Your Portfolio Now
ABM rides on broad segment growth, rising earnings expectations and strong liquidity, while margin pressure and competition remain key risks.
ABM -0.52% 
Best Value Stocks to Buy for September 8th
HRTG, E and BLMN made it to the Zacks Rank #1 (Strong Buy) value stocks list on September 8, 2026.
BLMN +1.42% 
Novo Nordisk's Semaglutide Meets Goal in Pediatric Obesity Study
NVO's semaglutide cuts BMI in children with obesity in phase III study, with 40.4% no longer classified as having obesity after 68 weeks.
SLIM -8.06% 
Is it Prudent to Retain Insulet Stock in Your Portfolio for Now?
PODD's Omnipod 5 adoption, product expansion and raised international growth outlook support its growth prospects despite competitive and cost pressures.
PODD +0.6% 
Hasbro: Magic Can Change What Investors Pay For The Whole Business
Hasbro (HAS) is rated Buy, driven by Magic: The Gathering's recurring revenue and robust gaming segment growth. Wizards of the Coast and Digital Gaming revenue grew 27%, supporting a projected 12% segment growth and 25.5–27% operating margins. My $130 price target (18x forward EPS) implies 40% upside, reflecting HAS's transition toward higher-margin, franchise-driven earnings.
HAS +0.89% 
Quantum Stock Surging on Revised Full-Year Outlook
Shares of IonQ Inc (NYSE:IONQ) are enjoying a 9.4% surge, trading $43.23 this morning after the quantum company hiked its full-year guidance.
QMCO +4.28% 
Luceco upgraded to 'buy' as Deutsche Bank raises target to 270p
Deutsche Bank has upgraded Luceco (LUCEL.L) to 'buy' from 'hold', raising its price target to 270p from 260p. Analyst Kevin Fogarty said interim results, due on September 22, should confirm that strong growth dynamics continued through the first half of the financial year.
DB +0.15% 
Trust Stamp integrates ID verification technology with Jack Henry's Banno platform
Trust Stamp Inc (NASDAQ:IDAI, ISE:AIID)'s driver's license verification technology is now available through Jack Henry's digital banking platform, the company said Tuesday. The AI-powered trust and identity solutions provider integrated its AAMVA Driver's License Data Verification (DLDV) solution using the Banno Digital Toolkit, the API framework underlying the Banno Digital Platform.
IDAI -0.29% 
Dow slides as oil nears $100, US-Canada trade tensions escalate
10:00am: Trade tensions heat up The Dow Jones led Wall Street lower at the open on Tuesday as rising oil prices and an escalating US-Canada trade dispute added to inflation concerns at the start of the holiday-shortened week. The Dow fell 588 points, or 1.1%, to 52,826, while the S&P 500 slipped 34 points, or 0.4%, to 7,684.
DOW -0.59% 
Silver Price Forecast: Bulls struggle below the 100-day SMA
Silver Price Forecast: Bulls struggle below the 100-day SMA
Bitcoin ETFs see $31M inflow as Ethereum ETFs bleed $48M in single-day divergence
The divergence in ETF flows highlights shifting investor sentiment and could signal broader market volatility and changing risk appetites. Bitcoin ETFs see $31M inflow as Ethereum ETFs bleed $48M in single-day divergence.
3 AI Optical Networking Stocks Positioned for the Data Center Buildout
AI-driven networking companies have been waiting for a sign to either continue to pull back or reinvigorate a bull run, but Ciena Corp.'s NYSE: CIEN Q3 earnings report may invite more questions than answers. Despite strong earnings and revenue, coupled with continued robust demand for AI and optical networking, shares fell after the report.
CIEN +5.6% 
Can MCD's Slower Expansion Pace Help Protect New-Restaurant Returns?
McDonald's slower expansion pace seeks to protect new-restaurant returns as higher development costs and consumer pressure reshape its growth timeline.
MCD -0.7% 
